Bottom line: The departure of former Google executive Hugo Barra from Xiaomi marks the end of a chapter for the smartphone maker, which stands only a 50-50 chance of surviving over the next 5 years in the cutthroat market.

Xiaomi's Barra heads back to US

The world was all abuzz in 2013 when Hugo Barra suddenly gave up his cozy position as a high executive at Google (Nasdaq: GOOG) to join a then-little-known Chinese smartphone maker called Xiaomi. Gossip swirled that his ...

Bottom line: TCL's new licensing deal with BlackBerry will end up as a quiet failure due to TCL's weak R&D skills and lack of consumer appeal to the BlackBerry name.  

TCL, BlackBerry in licensing tie-up

When does adding two negatives yield a positive? The answer is "never", but dying smartphone makers BlackBerry (Toronto: BB) and TCL (Shenzhen: 000100) are hoping that maybe this time will be different. Of course, it's easy for me to predict disaster for this particular ...

移动医疗App的推广成本正在变得越来越高。在用户端，靠大打广告，优惠促销刺激等手段虽然可以短期内增加一些新用户，但对长期的用户依从性并没有太大作用。而在医生端，采用类似药品销售的地推方式成本极高，正在逐渐变成海选，怎样让医生真正觉得工具有用并使用下去是一个大问题。

美国的移动医疗快速发展的一个重要特征就是，产品设计固然是第一环，但后面的渠道建设起到的决定性作用越来越明显。渠道策略的一种途径就是找最专业的平台——电子病历。电子病历是进入医院到达医生身边的强大渠道，药企早就看准这个渠道推送药品，因为他...